167 related articles for article (PubMed ID: 33470511)
1. Calpain-calpastatin system and cancer progression.
Nian H; Ma B
Biol Rev Camb Philos Soc; 2021 Jun; 96(3):961-975. PubMed ID: 33470511
[TBL] [Abstract][Full Text] [Related]
2. Calpain as a therapeutic target in cancer.
Shapovalov I; Harper D; Greer PA
Expert Opin Ther Targets; 2022 Mar; 26(3):217-231. PubMed ID: 35225722
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Calpain/Calpastatin Balance Is Involved in the Progression of Pulmonary Hypertension.
Wan F; Letavernier E; Abid S; Houssaini A; Czibik G; Marcos E; Rideau D; Parpaleix A; Lipskaia L; Amsellem V; Gellen B; Sawaki D; Derumeaux G; Dubois-Randé JL; Delcroix M; Quarck R; Baud L; Adnot S
Am J Respir Cell Mol Biol; 2016 Sep; 55(3):337-51. PubMed ID: 26974350
[TBL] [Abstract][Full Text] [Related]
4. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin.
Hanna RA; Campbell RL; Davies PL
Nature; 2008 Nov; 456(7220):409-12. PubMed ID: 19020623
[TBL] [Abstract][Full Text] [Related]
5. Effect of Ca2+ on binding of the calpains to calpastatin.
Kapprell HP; Goll DE
J Biol Chem; 1989 Oct; 264(30):17888-96. PubMed ID: 2553696
[TBL] [Abstract][Full Text] [Related]
6. Identification of mu-, m-calpains and calpastatin and capture of mu-calpain activation in endothelial cells.
Fujitani K; Kambayashi J; Sakon M; Ohmi SI; Kawashima S; Yukawa M; Yano Y; Miyoshi H; Ikeda M; Shinoki N; Monden M
J Cell Biochem; 1997 Aug; 66(2):197-209. PubMed ID: 9213221
[TBL] [Abstract][Full Text] [Related]
7. The calpain system is associated with survival of breast cancer patients with large but operable inflammatory and non-inflammatory tumours treated with neoadjuvant chemotherapy.
Storr SJ; Zhang S; Perren T; Lansdown M; Fatayer H; Sharma N; Gahlaut R; Shaaban A; Martin SG
Oncotarget; 2016 Jul; 7(30):47927-47937. PubMed ID: 27323818
[TBL] [Abstract][Full Text] [Related]
8. Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in endometrial cancer.
Salehin D; Fromberg I; Haugk C; Dohmen B; Georg T; Bohle RM; Bauerschlag D; Maass N; Friedrich M
Anticancer Res; 2010 Jul; 30(7):2837-43. PubMed ID: 20683020
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the intracellular distribution of mu-calpain, m-calpain, and calpastatin in proliferating human A431 cells.
Lane RD; Allan DM; Mellgren RL
Exp Cell Res; 1992 Nov; 203(1):5-16. PubMed ID: 1426051
[TBL] [Abstract][Full Text] [Related]
10. The calpain-calpastatin system and cellular proliferation and differentiation in rodent osteoblastic cells.
Murray SS; Grisanti MS; Bentley GV; Kahn AJ; Urist MR; Murray EJ
Exp Cell Res; 1997 Jun; 233(2):297-309. PubMed ID: 9194492
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of mu-calpain, m-calpain, and calpastatin from postmortem muscle. I. Initial steps.
Camou JP; Mares SW; Marchello JA; Vazquez R; Taylor M; Thompson VF; Goll DE
J Anim Sci; 2007 Dec; 85(12):3400-14. PubMed ID: 17878283
[TBL] [Abstract][Full Text] [Related]
12. Localization of the Ca(2+)-dependent proteinases and their inhibitor in normal, fasted, and denervated rat skeletal muscle.
Kumamoto T; Kleese WC; Cong JY; Goll DE; Pierce PR; Allen RE
Anat Rec; 1992 Jan; 232(1):60-77. PubMed ID: 1536466
[TBL] [Abstract][Full Text] [Related]
13. Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in ovarian cancer.
Salehin D; Fromberg I; Haugk C; Dohmen B; Georg T; Bohle RM; Bauerschlag D; Thill M; Friedrich M
Eur J Gynaecol Oncol; 2011; 32(6):628-35. PubMed ID: 22335024
[TBL] [Abstract][Full Text] [Related]
14. The calpain/calpastatin system has opposing roles in growth and metastatic dissemination of melanoma.
Raimbourg Q; Perez J; Vandermeersch S; Prignon A; Hanouna G; Haymann JP; Baud L; Letavernier E
PLoS One; 2013; 8(4):e60469. PubMed ID: 23565252
[TBL] [Abstract][Full Text] [Related]
15. Evidence for calpains in cancer metastasis.
Chen J; Wu Y; Zhang L; Fang X; Hu X
J Cell Physiol; 2019 Jun; 234(6):8233-8240. PubMed ID: 30370545
[TBL] [Abstract][Full Text] [Related]
16. Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains.
Moldoveanu T; Gehring K; Green DR
Nature; 2008 Nov; 456(7220):404-8. PubMed ID: 19020622
[TBL] [Abstract][Full Text] [Related]
17. Calpain-dependent cleavage of N-cadherin is involved in the progression of post-myocardial infarction remodeling.
Kudo-Sakamoto Y; Akazawa H; Ito K; Takano J; Yano M; Yabumoto C; Naito AT; Oka T; Lee JK; Sakata Y; Suzuki J; Saido TC; Komuro I
J Biol Chem; 2014 Jul; 289(28):19408-19. PubMed ID: 24891510
[TBL] [Abstract][Full Text] [Related]
18. Trichostatin A epigenetically increases calpastatin expression and inhibits calpain activity and calcium-induced SH-SY5Y neuronal cell toxicity.
Seo J; Jo SA; Hwang S; Byun CJ; Lee HJ; Cho DH; Kim D; Koh YH; Jo I
FEBS J; 2013 Dec; 280(24):6691-701. PubMed ID: 24200051
[TBL] [Abstract][Full Text] [Related]
19. Calpain-calpastatin interactions in epidermoid carcinoma KB cells.
Nagao S; Saido TC; Akita Y; Tsuchiya T; Suzuki K; Kawashima S
J Biochem; 1994 Jun; 115(6):1178-84. PubMed ID: 7982901
[TBL] [Abstract][Full Text] [Related]
20. Calpain system protein expression and activity in ovarian cancer.
Zhang S; Deen S; Storr SJ; Chondrou PS; Nicholls H; Yao A; Rungsakaolert P; Martin SG
J Cancer Res Clin Oncol; 2019 Feb; 145(2):345-361. PubMed ID: 30448882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
